Antibody titers in Group O platelet donors

Background and Objectives: The occurrence of hemolysis due to transfusion of ABO plasma-incompatible platelets (PLTs) is challenging. There has been no consensus for critical antibody titers in the transfusion community. This study was conducted to understand the trends of anti-A and anti-B antibody...

Full description

Bibliographic Details
Main Authors: Anita Amar Tendulkar, Puneet Ashok Jain, Sanjay Velaye
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:http://www.ajts.org/article.asp?issn=0973-6247;year=2017;volume=11;issue=1;spage=22;epage=27;aulast=Tendulkar
_version_ 1818669810273222656
author Anita Amar Tendulkar
Puneet Ashok Jain
Sanjay Velaye
author_facet Anita Amar Tendulkar
Puneet Ashok Jain
Sanjay Velaye
author_sort Anita Amar Tendulkar
collection DOAJ
description Background and Objectives: The occurrence of hemolysis due to transfusion of ABO plasma-incompatible platelets (PLTs) is challenging. There has been no consensus for critical antibody titers in the transfusion community. This study was conducted to understand the trends of anti-A and anti-B antibody titer levels in O group donors and to identify any specific patterns of distribution in relation to age and gender. Materials and Methods: A total of 1635 Group O PLT donors were randomly selected for this prospective study. Serial 2-fold doubling dilutions were prepared for each sample to calculate the titer of anti-A and anti-B in a standard 96 well micro-plate. Tube technique was used for comparison with the microplate method for 100 samples. Results: Out of 1635 donors, 1430 (87.46%) were males and 205 (12.54%) were females. The median titer for anti-A and anti-B was 128 with range from 4 to 2048. Spearman's correlation coefficient for microplate versus tube technique was estimated to be 0.803 (P < 0.01, two-tailed). 57.12% and 51.19% of all donors had titers ≥128 for anti-A and anti-B, respectively. The geometric mean of anti-A and anti-B was 155.7 and 137.28, respectively. The titers were significantly higher (P < 0.001) in female donors. An inverse relation between titer levels and age was seen. Conclusion: Microplate can be used to perform titers in resource-constrained settings. Screening for critical titers in O group donors is essential as they are more implicated in hemolytic transfusion reactions. In the absence of a global consensus on this topic, institutes may need to formulate their own guidelines on handling ABO plasma-incompatible PLT transfusions.
first_indexed 2024-12-17T06:58:08Z
format Article
id doaj.art-bc28aa0462b843c9b89b00177c36e258
institution Directory Open Access Journal
issn 0973-6247
1998-3565
language English
last_indexed 2024-12-17T06:58:08Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj.art-bc28aa0462b843c9b89b00177c36e2582022-12-21T21:59:22ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652017-01-01111222710.4103/0973-6247.200765Antibody titers in Group O platelet donorsAnita Amar TendulkarPuneet Ashok JainSanjay VelayeBackground and Objectives: The occurrence of hemolysis due to transfusion of ABO plasma-incompatible platelets (PLTs) is challenging. There has been no consensus for critical antibody titers in the transfusion community. This study was conducted to understand the trends of anti-A and anti-B antibody titer levels in O group donors and to identify any specific patterns of distribution in relation to age and gender. Materials and Methods: A total of 1635 Group O PLT donors were randomly selected for this prospective study. Serial 2-fold doubling dilutions were prepared for each sample to calculate the titer of anti-A and anti-B in a standard 96 well micro-plate. Tube technique was used for comparison with the microplate method for 100 samples. Results: Out of 1635 donors, 1430 (87.46%) were males and 205 (12.54%) were females. The median titer for anti-A and anti-B was 128 with range from 4 to 2048. Spearman's correlation coefficient for microplate versus tube technique was estimated to be 0.803 (P < 0.01, two-tailed). 57.12% and 51.19% of all donors had titers ≥128 for anti-A and anti-B, respectively. The geometric mean of anti-A and anti-B was 155.7 and 137.28, respectively. The titers were significantly higher (P < 0.001) in female donors. An inverse relation between titer levels and age was seen. Conclusion: Microplate can be used to perform titers in resource-constrained settings. Screening for critical titers in O group donors is essential as they are more implicated in hemolytic transfusion reactions. In the absence of a global consensus on this topic, institutes may need to formulate their own guidelines on handling ABO plasma-incompatible PLT transfusions.http://www.ajts.org/article.asp?issn=0973-6247;year=2017;volume=11;issue=1;spage=22;epage=27;aulast=TendulkarAntibody titershemolytic transfusion reactionO groupplatelet donor
spellingShingle Anita Amar Tendulkar
Puneet Ashok Jain
Sanjay Velaye
Antibody titers in Group O platelet donors
Asian Journal of Transfusion Science
Antibody titers
hemolytic transfusion reaction
O group
platelet donor
title Antibody titers in Group O platelet donors
title_full Antibody titers in Group O platelet donors
title_fullStr Antibody titers in Group O platelet donors
title_full_unstemmed Antibody titers in Group O platelet donors
title_short Antibody titers in Group O platelet donors
title_sort antibody titers in group o platelet donors
topic Antibody titers
hemolytic transfusion reaction
O group
platelet donor
url http://www.ajts.org/article.asp?issn=0973-6247;year=2017;volume=11;issue=1;spage=22;epage=27;aulast=Tendulkar
work_keys_str_mv AT anitaamartendulkar antibodytitersingroupoplateletdonors
AT puneetashokjain antibodytitersingroupoplateletdonors
AT sanjayvelaye antibodytitersingroupoplateletdonors